DE69920945D1 - Verfahren zur herstellung von arzneistoffpartikeln - Google Patents

Verfahren zur herstellung von arzneistoffpartikeln

Info

Publication number
DE69920945D1
DE69920945D1 DE69920945T DE69920945T DE69920945D1 DE 69920945 D1 DE69920945 D1 DE 69920945D1 DE 69920945 T DE69920945 T DE 69920945T DE 69920945 T DE69920945 T DE 69920945T DE 69920945 D1 DE69920945 D1 DE 69920945D1
Authority
DE
Germany
Prior art keywords
medicament particles
producing medicament
producing
particles
susceptible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920945T
Other languages
English (en)
Other versions
DE69920945T2 (de
Inventor
Catherine Boissier
Mari Juppo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69920945D1 publication Critical patent/DE69920945D1/de
Publication of DE69920945T2 publication Critical patent/DE69920945T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
DE69920945T 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln Expired - Lifetime DE69920945T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles
SE9804003 1998-11-23
PCT/SE1999/002152 WO2000030612A1 (en) 1998-11-23 1999-11-22 A method of producing drug particles

Publications (2)

Publication Number Publication Date
DE69920945D1 true DE69920945D1 (de) 2004-11-11
DE69920945T2 DE69920945T2 (de) 2005-08-25

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920945T Expired - Lifetime DE69920945T2 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln

Country Status (12)

Country Link
US (1) US6596315B1 (de)
EP (1) EP1133283B1 (de)
JP (1) JP4612191B2 (de)
AT (1) ATE278390T1 (de)
AU (1) AU754385B2 (de)
CA (1) CA2349711C (de)
DE (1) DE69920945T2 (de)
DK (1) DK1133283T3 (de)
ES (1) ES2228148T3 (de)
PT (1) PT1133283E (de)
SE (1) SE9804003D0 (de)
WO (1) WO2000030612A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
WO2003072127A1 (en) 2002-02-25 2003-09-04 Phasex Corporation Method for drying water-borne materials
EP1499296B1 (de) 2002-04-15 2012-04-04 MAP Pharmaceuticals Inc Formulierung aus feinen teilchen mit verflüssigten oder dichten gasen
AU2003262992A1 (en) 2002-08-30 2004-03-19 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
EP1624862B1 (de) 2003-05-08 2014-12-31 Nektar Therapeutics Teilchenförmige materialien
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1904219A4 (de) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc Teilchenbildungsverfahren
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
EP2425819A1 (de) 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Verfahren zur therapeutischen Verabreichung von DHE zur schnellen Linderung von Migräne bei gleichzeitiger Minimierung von Nebenwirkungsprofilen
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
BR9510510A (pt) * 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
AU709262B2 (en) * 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer

Also Published As

Publication number Publication date
JP4612191B2 (ja) 2011-01-12
JP2002530317A (ja) 2002-09-17
EP1133283A1 (de) 2001-09-19
ES2228148T3 (es) 2005-04-01
CA2349711A1 (en) 2000-06-02
CA2349711C (en) 2008-07-15
AU2010200A (en) 2000-06-13
EP1133283B1 (de) 2004-10-06
DE69920945T2 (de) 2005-08-25
DK1133283T3 (da) 2005-01-24
WO2000030612A1 (en) 2000-06-02
US6596315B1 (en) 2003-07-22
PT1133283E (pt) 2005-01-31
ATE278390T1 (de) 2004-10-15
AU754385B2 (en) 2002-11-14
SE9804003D0 (sv) 1998-11-23

Similar Documents

Publication Publication Date Title
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
DE50213524D1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
DE3486160D1 (de) Modifizierte lebende pseudo-rabies-viren, diese enthaltende impfstoffe gegen pseudo-rabies, verfahren zur herstellung und verfahren zur verwendung derselben.
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
DE69332310D1 (de) Verfahren zur herstellung von vorgefüllten, sterilen abgabevorrichtungen.
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
DE3680578D1 (de) Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DE68908223D1 (de) Verfahren zur herstellung von sehr reiner, dichter grossteiliger kieselsaeure.
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
DE1169296T1 (de) Niedrigdruckreaktor zur herstellung von aminen
DE59907055D1 (de) Verfahren zur herstellung von tetrachlorkohlenstoffarmen phosgen
DE59800058D1 (de) Karosseriehohlträger, sowie Verfahren zur dessen Herstellung mittels Innenhochdruck
DE60105209D1 (de) Verfahren zur Herstellung von niedrig substituierter Hydroxypropylcellulose-Partikeln
DE60032894D1 (de) Verfahren zur herstellung von stadtgas
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
ATE226931T1 (de) Verfahren zur herstellung von reinem cis-tramadol
DE69912827D1 (de) "ligand presenting assembly" (lpa), verfahren zu dessen herstellung und verwendungen
DE50300920D1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
ATE246250T1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
DE59800130D1 (de) Verfahren zur Herstellung von Organosilazanen
DE59811573D1 (de) Verbessertes Verfahren zur Herstellung von ungesättigten cyclischen Ethern
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition